Universitat de Barcelona
2022-06-02T12:13:47Z
2023-03-01T06:10:27Z
2022-03-01
2022-06-02T12:13:47Z
The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide, which is expected to correlate with significant medical and social costs. This study aimed to evaluate the clinical and economic burden of NAFLD in Catalonia at the hospital level.
Article
Versió acceptada
Anglès
Tractament de l'alcoholisme; Política sanitària; Cost de l'assistència sanitària; Alcoholism treatment; Medical policy; Cost of medical care
Informa Healthcare
Versió postprint del document publicat a: https://doi.org/10.1080/14737167.2021.1890586
Expert Review of Pharmacoeconomics & Outcomes Research, 2022, vol. 22, num. 2, p. 341-349
https://doi.org/10.1080/14737167.2021.1890586
(c) Informa Healthcare, 2022
Economia [1047]
